2/6
05:33 pm
crvo
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Medium
Report
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
2/5
06:09 am
crvo
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Medium
Report
CervoMed (NASDAQ:CRVO) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
12/18
08:05 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
12/18
07:11 am
crvo
CervoMed (NASDAQ:CRVO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/4
05:00 pm
crvo
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
Medium
Report
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
12/2
09:04 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
12/2
07:00 am
crvo
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
Medium
Report
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
11/24
07:00 am
crvo
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
Medium
Report
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference